ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1290

A Multitrait-Multimethod Matrix Approach to the Construct Validity of Patient Reported Outcomes Measurement Information System Computerized (PROMIS) Adaptive Tests (CAT) in Systemic Lupus Erythematous

Mitra Moazzami1, Patricia Katz2, Dennisse Bonilla3, Lisa Engel4, Jiandong Su5, Pooneh Akhavan6, Nicole Anderson5, Oshrat Tayer-Shifman7, Dorcas Beaton8 and Zahi Touma9, 1George Washington University School of Medicine, Washington, DC, 2University of California, San Francisco, Novato, CA, 3University Health Network, Toronto, Canada, 4University of Manitoba, Toronto, ON, Canada, 5University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 6Univesity of Toronto, Toronto, ON, Canada, 7Meir Medical Center, Raanana, Israel, 8Institue for Work and Health, Toronto, ON, Canada, 9University of Toronto, Toronto, ON, Canada

Meeting: ACR Convergence 2020

Keywords: Patient reported outcomes, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II: Comorbidities

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Use of The Patient Reported Outcomes Measurement Information System computerized adaptive test (PROMIS-CAT) in adults with systemic lupus erythematous (SLE) is an emerging research field. Previous studies showed PROMIS short forms are reliable and valid against the SF-36 in persons with SLE. Our previous research found that PROMIS-CAT scores have good-excellent reliability and moderate-high correlation with legacy instruments (e.g., Medical Outcomes Study Short-Form 36 Health Survey, (SF-36)). Here we aim to elaborate on the construct validity of PROMIS-CAT.

Methods: Consecutive consenting SLE patients (≥18 years old) attending a single center between July 2018 – Jan 2020 completed PROMIS-CAT and the SF-36 during clinical visits. Construct validity was evaluated comparing and contrasting hypothesized convergent correlations and divergent correlations using a multitrait-multimethod matrix approach comparing 10 PROMIS-CAT domain scores (Physical Function, Mobility, Pain Behaviour, Pain Interference, Fatigue, Anger, Anxiety, Depression, Ability to Participate in Social Roles, Satisfaction with Social Roles) with SF-36 subscale scores (Physical Function, Role Physical, Bodily Pain, Vitality, Role Emotional, General Health, Mental Health, Social Function).The multitrait-multimethod matrix approach compares a similar construct using 2 different tools (e.g. PROMIS-CAT and SF-36). We hypothesised that convergent correlations on average would have higher correlations than divergent correlations between SF-36 and PROMIS-CAT domains.

Construct validity was also tested using additional five a priori hypotheses to explore the relationships of PROMIS-CAT domains with corresponding SF-36 domains. We hypothesized that the following associations would be found, with at least moderately positive associations (r >0.3):

1) PROMIS-CAT Physical Function the SF-36 domains of Physical Function and Role Physical.

2) PROMIS-CAT Anger, Anxiety, and Depression with SF-36 Emotional Health scores.

3) PROMIS-CAT Ability to Participate in Social Roles and Satisfaction with SF-36 Social Roles.

4) PROMIS-CAT Fatigue with SF-36 Vitality.

5) PROMIS-CAT Depression with SF-36 Mental Health.

Results: Of the 227participants in the cohort, 90.3% were female, mean age at study enrolment was 48.6 ± 14.1 years, and mean disease duration was 18.5 ± 12.4 years (Table 1). The multitrait-multimethod matrix examining construct validity confirmed that the average convergent correlations were greater than the average divergent correlations for all domains (Table 2). All five a priori hypotheses were satisfied with moderate to strong correlations (Spearman correlation, r=0.55-0.87) between PROMIS-CAT and most SF-36 domains.

Conclusion: Our results provide evidence on the validity of PROMIS-CAT in an SLE Canadian cohort. The use of multi-trait multimethod analyses highlighted the convergent and divergent construct validity compared to legacy instrument. This is the first study to use multitrait-multimethod matrix analysis to establish validity support for the PROMIS-CAT and our results demonstrate encouraging results.


Disclosure: M. Moazzami, None; P. Katz, None; D. Bonilla, None; L. Engel, None; J. Su, None; P. Akhavan, None; N. Anderson, None; O. Tayer-Shifman, None; D. Beaton, None; Z. Touma, None.

To cite this abstract in AMA style:

Moazzami M, Katz P, Bonilla D, Engel L, Su J, Akhavan P, Anderson N, Tayer-Shifman O, Beaton D, Touma Z. A Multitrait-Multimethod Matrix Approach to the Construct Validity of Patient Reported Outcomes Measurement Information System Computerized (PROMIS) Adaptive Tests (CAT) in Systemic Lupus Erythematous [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/a-multitrait-multimethod-matrix-approach-to-the-construct-validity-of-patient-reported-outcomes-measurement-information-system-computerized-promis-adaptive-tests-cat-in-systemic-lupus-erythematous/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-multitrait-multimethod-matrix-approach-to-the-construct-validity-of-patient-reported-outcomes-measurement-information-system-computerized-promis-adaptive-tests-cat-in-systemic-lupus-erythematous/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology